Nihon Kohden (OTCMKTS:NHNKY) Sees Strong Trading Volume – Here’s What Happened

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw unusually-strong trading volume on Wednesday . 187,851 shares traded hands during mid-day trading, an increase of 615% from the previous session’s volume of 26,287 shares.The stock last traded at $8.58 and had previously closed at $8.4425.

Analyst Ratings Changes

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Nihon Kohden currently has an average rating of “Buy”.

Nihon Kohden Stock Performance

The firm has a market cap of $1.47 billion, a PE ratio of 14.53 and a beta of 0.39. The stock has a 50-day simple moving average of $9.18 and a two-hundred day simple moving average of $10.13.

Nihon Kohden (OTCMKTS:NHNKY) last announced its quarterly earnings results on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. The firm had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. As a group, sell-side analysts anticipate that Nihon Kohden Corporation will post 0.61 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.